Aflac (AFL) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
23 Apr, 2026Company overview and business model
Provides supplemental health and life insurance products in Japan and the U.S., focusing on financial protection for policyholders facing illness or injury.
Authorized to conduct insurance business in all 50 U.S. states, D.C., several territories, and Japan.
Emphasizes prompt cash benefits for eligible claims, aiming to reduce policyholder financial stress.
Risk factors and disclosures
Faces risks from global capital market conditions, inflation, interest rate fluctuations, and currency exchange rates.
Business concentration in Japan and limited availability of yen-denominated investments present exposure risks.
Subject to extensive regulation, cybersecurity threats, litigation, and operational risks from third-party vendors.
Catastrophic events, reputational risks, and executive succession are highlighted as material risks.
Additional risks are detailed in the most recent Annual Report on Form 10-K and other SEC filings.
Use of proceeds and capital allocation
Will not receive any proceeds from the sale of shares; all proceeds go to the selling stockholder.
Latest events from Aflac
- Net earnings rose 37.7% to $825M, with strong capital returns and resilient segment results.AFL
Q2 2026 - Independent chairman proposal failed; all directors and key proposals approved by wide margins.AFL
AGM 2026 - Strong 2025 results with high market share, stable earnings, and robust capital returns.AFL
Morgan Stanley Japan Financials Conference presentation - Strategic innovation and disciplined growth drive robust financial outlook and capital returns.AFL
Analyst Day 2024 - Disciplined growth, innovation, and AI adoption drive strong performance and capital flexibility.AFL
Morgan Stanley US Financials Conference 2026 - Net earnings surged to $1.0 billion, with strong margins and $1.3 billion in capital returns.AFL
Q1 2026 - Q3 net earnings rose to $1.6B, with strong Japan sales and $1B in share repurchases.AFL
Q3 2025 - Q3 net loss from investment losses, but adjusted EPS up 17.4% and capital returns increased.AFL
Q3 2024 - Q4 net and adjusted EPS soared on investment gains, with strong capital returns and dividend growth.AFL
Q4 2024